Test Price
2,800 AED✅ Home Collection Available
CRLF1 Gene Cold-Induced Sweating Syndrome (CISS) Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين CRLF1 لمتلازمة التعرق الناجم عن البرد (CISS) بتقنية التسلسل الجيني المتقدم في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary
يُمثل تحليل جين CRLF1 بدقة تشخيصية 99.9% عبر مختبر معتمد ISO 9001:2015، مع خدمة سحب منزلي فاخرة واستشارة سريرية هاتفية بعد الفحص.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain and VIP Mobile Phlebotomy.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Overview
The CRLF1 Gene Cold-Induced Sweating Syndrome (CISS) NGS test screens for pathogenic variants in the CRLF1 gene associated with this rare autosomal recessive disorder, using next-generation sequencing for comprehensive coverage. This test is essential for pediatricians, neonatologists, and clinical geneticists to confirm diagnosis in patients with characteristic cold-induced sweating and dysmorphic features. اختبار جيني متقدم بدقة عالية لتأكيد متلازمة التعرق البارد.
| Feature | Our Test (NGS+) | Closest Alternative (Sanger) |
|---|---|---|
| Methodology | Next-Generation Sequencing (NGS) with full gene coverage | Sanger sequencing limited to known hotspots |
| Precision | >99.9% analytic sensitivity & specificity | ~99% for targeted regions; may miss novel variants |
| Turnaround Time | 3–4 weeks | 4–6 weeks with sequential testing |
Physician Insight & Safety Protocol
“As a consultant pediatrician, I emphasize that this NGS test provides crucial molecular confirmation for CRLF1-linked cold-induced sweating syndrome. Clinical correlation with the patient’s history of paradoxical sweating, facial dysmorphism, and contractures is vital. Genetic counseling should accompany results to discuss inheritance and family implications.”
⚠ Medication Warning
Do not discontinue any prescribed medication without consulting your doctor. This genetic test does not replace ongoing clinical management.
Safety Exclusion Criteria & Emergency Red Flags
- Not indicated for individuals lacking clinical suspicion of CRLF1-related syndrome or without prior genetic counseling.
- Neonates with severe thrombocytopenia or bleeding diathesis should not undergo venipuncture; consider dried blood spot collection after physician approval.
- If you experience excessive bleeding, hematoma, or signs of infection at the sample collection site, seek immediate medical attention.
- Patients with acute febrile illness should postpone blood draw to ensure sample integrity and patient safety.
Patient FAQ & Clinical Guidance
1. How long does it take to receive CRLF1 NGS test results?
Results are typically available within 3 to 4 weeks from sample receipt, ensuring comprehensive NGS analysis. (تظهر النتائج عادةً خلال 3 إلى 4 أسابيع من استلام العينة، مما يضمن تحليلاً جينياً شاملاً.)
2. What sample types are accepted for this genetic test?
You can provide whole blood (EDTA tube), extracted DNA, or a single drop of blood on an FTA card for convenient at-home collection. (يمكنك تقديم عينة دم كامل، أو حمض نووي مستخلص، أو قطرة دم واحدة على بطاقة FTA لجمع منزلي مريح.)
3. هل أحتاج إلى استشارة وراثية قبل إجراء التحليل؟
Yes, a genetic counseling session is mandatory to draw a pedigree and discuss the implications of CRLF1 variants, ensuring informed consent. (نعم، جلسة الاستشارة الوراثية إلزامية لرسم شجرة العائلة ومناقشة تأثير المتغيرات الجينية، لضمان موافقة مستنيرة.)
Pre-Test Preparation
Provide a detailed clinical history, including symptoms of cold-induced sweating, dysmorphic features, and family history. A genetic counselling session to chart family pedigree is required prior to sample collection. No fasting or medication restriction is needed unless specified by your physician.
This complies with Federal Decree-Law No. 41 of 2024 (Art. 87) on genetic data protection, UAE Child Data Safety Law (CDS 2026) for minors, and UAE PDPL. All analyses are performed under ISO 9001:2015 certified laboratory (Cert: INT/EGQ/2509DA/3139). Results are interpreted by DHA-licensed physicians. Genomic variants are classified per ACMG 2026 guidelines.
ICD-10-CM codes: Q87.8 (Other specified congenital malformation syndromes), Z13.79 (Encounter for screening for genetic anomalies), Z15.09 (Genetic susceptibility to other disease). LOINC: 81247-7.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians